Hansa Biopharma AB
Closed portfolio snapshot
According to ClinicalTrials.gov-derived indexes, Hansa Biopharma AB sits in the upper quartile of US sponsors by registered trial count (#1,806 of 15,742 sponsors by registered trial count).
Hansa Biopharma AB: 7 sponsored US clinical trials, none currently recruiting.
Hansa Biopharma AB sponsors 7 registered US clinical trials on ClinicalTrials.gov, none currently recruiting, and 4 completed. 2 of these trials are in Phase 3-4 (later-stage) and 3 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Kidney Transplantation in Highly Sensitized Patients, with 2 trials.
Upper-quartile sponsor footprint
Hansa Biopharma AB sits in the upper quartile of the sponsor corpus (#1,806 of 15,742 sponsors by registered trial count) - denser than most sponsors, still short of the top-decile hubs.
Indexed trials (enrollment closed)
7 total, page 1 of 1
Survival and Dialysis Independency in Highly Sensitized Patients After Desensitization With Imlifidase and Tx of Kidneys
NCT05714514
A Study With Imlifidase in Anti-GBM Disease
NCT05679401
A Study to Investigate DSA Rebound in Patients Treated With Imlifidase Prior to Transplantation
NCT05049850
Renal Function in Highly Sensitized Patients 1 Year After Desensitization With Imlifidase Prior to DD Kidney Tx
NCT04935177
An Efficacy and Safety Study of Imlifidase in Treatment of Antibody-Mediated Rejection in Kidney Transplant Patients
NCT03897205
A Follow up Study of Patients Treated With Imlifidase Prior to Kidney Transplantation
NCT03611621
A Phase II Study to Evaluate the Efficacy of IdeS to Desensitize Transplant Patients With a Positive Crossmatch Test
NCT02790437
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 2 | 3 |
| Phase 3 | 2 |
Therapeutic Areas
How the Hansa Biopharma AB archive is shaped
7 indexed studies, none listed as recruiting (0% open); 4 completed (57%).
Phase mix: 2 late (III/IV) vs 3 early (I/II) (balanced across stages).
Top condition: Kidney Transplantation in Highly Sensitized Patients (2 trials), 1 other listed.
How to read a closed sponsor archive
When recruiting_count is zero, the indexed set is completed or otherwise not open. Phase tilt still describes where archived studies sat on the investigational pathway. Re-check ClinicalTrials.gov before acting.
Hansa Biopharma AB: archived-pipeline peers nationwide
Peers matched on 7 indexed studies with no current recruiting: volume and archive shape, not condition overlap.
Hansa Biopharma AB sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 7 archived trials
- 3M · 7 trials · 0% recruiting
- 4Life Research · 7 trials · 0% recruiting
- 89bio · 7 trials · 29% recruiting
- Abbott Diagnostics Division · 7 trials · 0% recruiting
Sponsors with similar archive density (± trial count)
- 10xBio · 0% recruiting · 3 trials
- 22nd Century Group · 0% recruiting · 3 trials
- 23andMe · 0% recruiting · 6 trials
- 3-C Institute for Social Development · 0% recruiting · 14 trials
Related
What to do with this Hansa Biopharma AB page
7 registered trials is a research-attention snapshot, not an endorsement of Hansa Biopharma AB or any single study.
- None of Hansa Biopharma AB's trials are currently recruiting in this registry; that can change as new trials post, or check the broader research index. Browse research indexes
- Kidney Transplantation in Highly Sensitized Patients is the condition Hansa Biopharma AB studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Kidney Transplantation in Highly Sensitized Patients trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Hansa Biopharma AB pipeline card: 7 registered trials from official public datasets.Report a data error.